- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Mobile CT sales fuel Analogic revenues
Sales of a new portable CT scanner helped Analogic post recordrevenues and earnings for its fourth quarter and fiscal 1996 (end-July).Analogic also saw gains in other areas of its medical technologybusiness, according to officials with the Peabody, MA,
Sales of a new portable CT scanner helped Analogic post recordrevenues and earnings for its fourth quarter and fiscal 1996 (end-July).Analogic also saw gains in other areas of its medical technologybusiness, according to officials with the Peabody, MA, vendor.
For the year, Analogic posted revenue of $230.5 million, up10% compared with sales of $208.8 million the year before. Netincome for 1996 stood at $13.1 million, up from $12.7 millionin fiscal 1995.
Despite the year-over-year gains, it was in the fourth quarterthat Analogic saw real growth. Revenues for the most recent periodwere a record $70.4 million, up 25% compared with $56.3 millionin the same period last year. Net income grew to $5.9 million,compared with $4.2 million in the fourth quarter of 1995.
The revenue growth is due to higher sales in Analogic's medicaltechnology business, according to senior vice president and treasurerJohn Tarello. In particular, Analogic experienced strong fourth-quartersales of a portable CT scanner that went into production in January,Tarello said.
Analogic has licensed the system to Philips Medical Systems,which sells the unit in two versions as Tomoscan/M and Tomoscan/EG(SCAN 2/15/95). Philips debuted the scanner to the Asian marketat the International Congress of Radiology meeting in Beijinglast June (SCAN 7/17/96).
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
